Expert cautions against promoting CBD gel for epilepsy seizures, after study unveils long-term impact

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Around three quarters of over-the-counter (OTC) topical cannabidiol (CBD) products in the US are inaccurately labeled, according to a study by John Hopkins Medical... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As the cannabinoid (CBD) space proliferates amid consumer demands ranging from immunity to mood, industry is simultaneously observing a rise of alternatives. Companies... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The UK’s Food and Standard Agency (FSA) has reached a “milestone” after authorizing almost 12,000 cannabinoid (CBD) products to its public list of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The UK can gain global competitive advantage in cannabinoids (CBD) if it chooses to adopt a series of regulatory amendments put forth in a newly published report... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Several UK government departments are seeking to educate the food industry and individuals in official control laboratories about cannabidiol (CBD) in food supplements.... Read More

trans